The findings suggest that the use of cadaveric dura mater patches in cardiac surgery seeded amyloid pathology, leading to ...
Researchers at Washington University School of Medicine have developed an experimental immunotherapy they say could change how Alzheimer’s disease is treated — and potentially delayed — particularly ...
On 20 March, at the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological ...
A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...
CEREBRAL lymphatic dysfunction is emerging as a promising therapeutic target in Alzheimer’s disease treatment and research.
A newly identified protein pair may drive brain cell death in Alzheimer’s, offering a clearer explanation of how the disease progresses.
A blood biomarker for Alzheimer's disease also indicates damage to the heart and kidneys, complicating early and clinical ...
Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...
Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential ...
Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results